ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Clinical practice"

  • Abstract Number: 1046 • 2017 ACR/ARHP Annual Meeting

    Biological and Targeted Synthetic Dmards’ Prior Authorization Time Is Significantly Reduced with Pharmacy Presence in the Rheumatology Clinic

    Wendy Ramey1, Kristine M. Lohr2, Matt Zeltner1, Haley Herrell Postonl1, Andrew Johannemann1, Aric D. Schadler1 and Aleksander Lenert3, 1University of Kentucky, Lexington, KY, 2Rheumatology, University of Kentucky, Lexington, KY, 3Internal Medicine, Div. of Rheumatology, University of Kentucky, Lexington, KY

    Background/Purpose: Treatment with biological DMARDs (bDMARD) and targeted synthetic DMARDs (tsDMARD) has led to improved outcomes for chronic rheumatic diseases. Current treat-to-target (T2T) strategy relies…
  • Abstract Number: 2452 • 2017 ACR/ARHP Annual Meeting

    In Real-World Clinical Practice, Patients Switching from IV to SC Abatacept Maintain Clinical Efficacy after Switch

    Rieke Alten1, HM Lorenz2, X Mariette3, H Nüßlein4, M Galeazzi5, F Navarro6, M Chartier7, J Heitzmann8, C Rauch9 and M Le Bars7, 1Schlosspark-Klinik University Medicine, Berlin, Germany, 2University Hospital, Heidelberg, Germany, 3Université Paris-Sud, Paris, France, 4University of Erlangen-Nuremberg, Nuremberg, Germany, 5University of Siena, Siena, Italy, 6Hospital Universitario Virgen Macarena, Seville, Spain, 7Bristol-Myers Squibb, Rueil-Malmaison, France, 8Excelya, Boulogne-Billancourt, France, 9Bristol-Myers Squibb, Munich, Germany

    Background/Purpose: Patients (pts) with RA may be able to switch from IV to SC abatacept with no loss of efficacy or safety concerns, but data…
  • Abstract Number: 1078 • 2017 ACR/ARHP Annual Meeting

    Initial Combination Therapy Versus Step-up Therapy Is More Effective and Less Costly As a Treat to Target Strategy for RA: A Markov Model Based upon the Dutch Rheumatoid Arthritis Monitoring Registry Cohorts

    Celine J. van de Laar1, Laura M.M. Steunebrink2, Martijn A.H. Oude Voshaar3 and Harald E. Vonkeman4, 1Transparency in Healthcare B.V., Hengelo, Netherlands, 2Medisch Spectrum Twente - Arthritis Center Twente, Enschede, Netherlands, 3University of Twente, Department of Psychology, Health and Technology, Enschede, Netherlands, 4koningsplein, Medisch Spectrum Twente - Arthritis Center Twente, Enschede, Netherlands

    Background/Purpose: Adjusting medication of patients with rheumatoid arthritis (RA) until predefined disease activity targets are met, i.e. Treat to Target (T2T), is the currently recommended…
  • Abstract Number: 2530 • 2017 ACR/ARHP Annual Meeting

    Clinical Specialty Setting As a Determinant for Disease Management in Patients with Psoriatic Arthritis: An Interim Analysis of the Cross-Sectional Observational Study

    Wolf-Henning Boehncke1, Rudolf Horváth2, Ediz Dalkiliç3, Sȏnia A L Lima4, Masato Okada5, Maja Hojnik6, Fabiana Ganz7 and Ennio Lubrano8, 1Geneva University Hospital and University of Geneva, Geneva, Switzerland, 2Department of Pediatric and Adult Rheumatology, University Hospital Motol, Prague, Czech Republic, 3Department of Internal Medicine, Division of Rheumatology, Uludag University School of Medicine, Gorukle, Bursa, Turkey, 4ABC Medical School, Santo André, Brazil, 5Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, 6AbbVie, Ljubljana, Slovenia, 7AbbVie AG, Baar, Switzerland, 8Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy

    Background/Purpose: Evidence suggests that timely and effective management can improve long-term outcomes in patients (pts) with psoriatic arthritis (PsA); however factors influencing treatment management decisions…
  • Abstract Number: 1088 • 2017 ACR/ARHP Annual Meeting

    Staff Protocol in Rheumatology Clinics Reduces Population-Level Rate of High Blood Pressure

    Christie M. Bartels1, Edmond Ramly2, Emmanuel Sampene3, Diane Lauver4, Patrick McBride5 and Heather Johnson5, 1Rheumatology/Medicine, University of Wisconsin - Madison, Madison, WI, 2Industrial and Systems Engineering, University of Wisconsin College of Engineering, Madison, WI, 3Biostatistics, University of Wisconsin School of Medicine and Public Health, Madison, WI, 4University of Wisconsin-Madison School of Nursing, Madison, WI, 5Cardiology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: The Centers for Disease Control and Prevention director has said “nothing will save more lives” than protocols to control blood pressure (BP). BP is…
  • Abstract Number: 2532 • 2017 ACR/ARHP Annual Meeting

    The Relationship between the Degree of Skin Involvement and Joint Activity in Patients with Psa: Experience from the Corrona Registry

    Philip J Mease1, Carol J. Etzel2, Jeffrey Lisse3, April W Armstrong4, William J Huster3, Sabrina Rebello2, Rhiannon Dodge2, Talia M Muram3, Sarah Al Sawah3, Mwangi J Murage3, Jeffrey D Greenberg2 and William Malatestinic3, 1Department of Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, 2Corrona, LLC, Southborough, MA, 3Eli Lilly and Company, Indianapolis, IN, 4Keck School of Medicine, University of Southern California, Los Angeles, CA

    Background/Purpose:   Prior studies have shown an inconsistent relationship between skin and joint symptoms in patients with comorbid PsO and PsA1-3.  The objective of the…
  • Abstract Number: 1118 • 2017 ACR/ARHP Annual Meeting

    Diabetes and Gout: Real-World Evidence Evaluating Patient Characteristics, Treatment Patterns, and Health Care Utilization

    Douglas C.A. Taylor1, An-Chen Fu1 and Robert Morlock2, 1Ironwood Pharmaceuticals, Inc., Cambridge, MA, 2YourCareChoice, Ann Arbor, MI

    Background/Purpose: Gout and type 2 diabetes mellitus (T2DM) are common in the United States (US), but little is known about potential associations of T2DM and…
  • Abstract Number: 2533 • 2017 ACR/ARHP Annual Meeting

    Current Psa Therapy Impacts the Relationship between the Degree of Skin Invlovment and Joint Activity

    Philip J Mease1, Carol J. Etzel2, Jeffrey Lisse3, April W Armstrong4, William J Huster3, Sabrina Rebello2, Rhiannon Dodge2, Talia M Muram3, Sarah Al Sawah3, Mwangi J Murage3, Jeffrey D Greenberg2 and William Malatestinic3, 1Swedish Medical Center and University of Washington, Seattle, WA, 2Corrona, LLC, Southborough, MA, 3Eli Lilly and Company, Indianapolis, IN, 4Keck School of Medicine, University of Southern California, Los Angeles, CA

    Background/Purpose: Simultaneous control of joint symptoms and degree of skin involvement has been linked to improvement in health-related quality of life in patients with coexistent…
  • Abstract Number: 1233 • 2017 ACR/ARHP Annual Meeting

    Establishing and Maintaining a Volunteer Charity Rheumatology Clinic: One Clinic’s Experience

    Narender Annapureddy1, Michelle J. Ormseth2, Julie Barnes3 and James Gore4, 1Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, 2Rheumatology, Vanderbilt Medical Center, Nashville, TN, 3Vanderbilt University Medical Center, Nashville, TN, 4Vanderbilt Rheumatology Cool Springs, Franklin, TN

    Establishing and Maintaining a Volunteer Charity Rheumatology Clinic: One Clinic’s Experience Background/Purpose: In 2015, about 16% of adults under age 65 in Tennessee were uninsured.…
  • Abstract Number: 114 • 2017 Pediatric Rheumatology Symposium

    Clinical Features and Treatment Outcomes in Down’s Arthropathy

    Jordan T. Jones1 and Leena Danawala2, 1Rheumatology Division, Children's Mercy Kansas City, Kansas City, MO, 2University of Missouri-Kansas City School of Medicine, Kansas City, MO

    Background/Purpose: Crude prevalence estimates indicate Down’s Arthropathy (DA) is 3-8 times more common than juvenile idiopathic arthritis (JIA), however, DA is still largely under recognized…
  • Abstract Number: 81 • 2016 ACR/ARHP Annual Meeting

    Understanding the Importance of a Patient’s Role in the Management of RA: Physician- and Patient-Based Survey

    Ara Dikranian1, James Galloway2, Joern Kekow3, Cristiano A.F Zerbini4, Maria de la Vega5, Gavin Lee6, Anna Maniccia7, Eustratios Bananis8, Dario Ponce de Leon9 and Allan Gibofsky10, 1San Diego Arthritis Medical Clinic, San Diego, CA, 2King's College, and King´s College Hospital, London, United Kingdom, 3University of Magdeburg, Clinic of Rheumatology, Magdeburg, Germany, 4Centro Paulista de Investigação Clinica, São Paulo, Brazil, 5CEIM Investigaciones Médicas, Buenos Aires, Argentina, 6Hong Kong Sanatorium & Hospital, Hong Kong SAR, China, 7Pfizer Inc, New York, NY, 8Pfizer Inc, Collegeville, PA, 9Pfizer Inc, Lima, Peru, 10Rheumatology, Weill Cornell Medicine, and Hospital for Special Surgery, New York, NY

    Background/Purpose: RA is a chronic, debilitating condition for which there is no cure. To identify and better understand the perspectives of both healthcare providers (HCPs)…
  • Abstract Number: 3138 • 2016 ACR/ARHP Annual Meeting

    Sustained Improvement in Follow-up of Hypertension in Rheumatology Patients: Results of an Intervention Sustainability Assessment

    Edmond Ramly1,2, Daniel Panyard3, Diane Lauver4, Emmanuel Sampene5, Zhanhai Li5, Heather Johnson6, Patrick McBride6, Kristin Steffen Lewicki7 and Christie M. Bartels8, 1Industrial and Systems Engineering, University of Wisconsin-Madison College of Engineering, Madison, WI, 2Department of Medicine, University of Wisconsin-Madison, Madison, WI, 3Population Health, University of Wisconsin School of Medicine and Public Health, Madison, WI, 4University of Wisconsin-Madison School of Nursing, Madison, WI, 5Biostatistics, University of Wisconsin School of Medicine and Public Health, Madison, WI, 6Cardiology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 7Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 8Rheumatology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Hypertension (HTN) is the most prevalent comorbid cardiovascular disease (CVD) risk factor among adults with rheumatic conditions.  However, we previously found that high blood…
  • Abstract Number: 90 • 2016 ACR/ARHP Annual Meeting

    Impacts of Anti-TNF Treatment on Improvement in Work Place and Household Productivity in Patients with Psoriatic Arthritis

    Omer Karadag1, Ediz Dalkilic2, Ahmet Mesut Onat3, Orhan Kucuksahin4, Timucin Kasifoglu5, Bunyamin Kisacik6, Omer Nuri Pamuk7, Neslihan Yilmaz8, Suleyman Serdar Koca9, Veli Yazisiz10, Pinar Talu Ocakci11, Mehmet Sayarlioglu12, Ender Terzioglu13, Sukran Erten14,15, Mustafa Ferhat Oksuz16 and Umut Kalyoncu1, 1Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 2Department of Rhematology, Uludag University Faculty of Medicine, Bursa, Turkey, 3Department Of Internal Medicine, Division of Rheumatology, Gaziantep University, Gaziantep University,Division of Rheumatology, Gaziantep, Turkey, 4Rheumatology, Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey, 5Rheumatology, Eskisehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey, 6Rheumatology Department, Gaziantep University School of Medicine, Gaziantep, Turkey, 7Rheumatology, Trakya University Faculty of Medicine, Edirne, Turkey, 8Department of Rheumatology, Bilim University Faculty of Medicine, Istanbul, Turkey, 9Department of Rheumatology Faculty of Medicine Firat University, Elazig, Turkey, 10Rheumatology, Akdeniz University Faculty of Medicine, Antalya, Turkey, 11Rheumatology, İzmir University Faculty of Medicine, izmir, Turkey, 12Rheumatology, Ondokuz Mayis University Faculty of Medicine, Samsun, Turkey, 13Division of Rheumatology, Akdeniz University Faculty of Medicine, Antalya, Turkey, 14Rheumatology, Ataturk Training and Research Hospital, Ankara, Turkey, 15Rheumatology, Yildirim Beyazit University Faculty Of Medicine, Ankara, Turkey, 16Rheumatology, Uludag University Faculty of Medicine, Bursa, Turkey

    Background/Purpose: Psoriatic arthritis (PsA) is a unique inflammatory arthritis that affects the skin, nails, and the joints. Most of the patients consider PsA to have…
  • Abstract Number: 3150 • 2016 ACR/ARHP Annual Meeting

    The Initial Dose of Methotrexate per Weight Is Determinant of Disease Activity and Early DAS28 Remission in DMARD-Naive Early Rheumatoid Arthritis Patients Receiving Usual Care

    Tuomas Rannio1, Juha Asikainen2, Pekka Hannonen2, Timo Yli-Kerttula3, Päivi Ekman4, Laura Kuusalo5, Laura Pirilä6, Markku Mali7, Marja Puurtinen-Vilkki7, Satu Kortelainen7, Johanna Paltta6, Kirsi Taimen7, Markku J. Kauppi8, Kari Laiho9, Satu Nyrhinen9, Heidi Mäkinen10, Pia Isomäki10, Terhi Uotila10, Kalle Aaltonen11, Hannu Kautiainen12 and Tuulikki Sokka-Isler1, 1Rheumatology, Jyvaskyla Central Hospital, Jyvaskyla, Finland, 2Jyvaskyla Central Hospital, Jyväskylä, Finland, 3Sairaalantie 3, Satakunta Central Hospital, Rauma, Finland, 4Satakunta Central Hospital, Rauma, Finland, 5Rheumatology, Turku University Central Hospital, Turku, Finland, 6Turku University Hospital, Turku, Finland, 7Turku University Central Hospital, Turku, Finland, 8Department of Rheumatology, Päijät-Häme Central Hospital, Lahti, Finland, 9Päijät-Häme Central Hospital, Lahti, Finland, 10Tampere University Hospital, Tampere, Finland, 11Helsinki University, Helsinki, Finland, 12Unit of Primary Health Care, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

      Background/Purpose: Methotrexate (MTX) is considered as the anchor disease modifying antirheumatic drug (DMARD) in treatment of rheumatoid arthritis (RA). However, there is no advice…
  • Abstract Number: 267 • 2016 ACR/ARHP Annual Meeting

    Diffuse Idiopathic Skeletal Hyperostosis: Can We Identify Different Clinicoradiological Patterns?

    Teresa Clavaguera1, Ramon Valls2 and Mari Carmen Rodriguez-Jimeno2, 1Unitat de Reumatologia, Hospital de Palamós, Girona, Spain, 2rheumatology, Hospital de Palamós, Palamós, Spain

    Background/Purpose:  Diffuse Idiopathic Skeletal Hyperostosis (DISH) was described based on vertebral radiological signs (Resnick). Subsequently, Utsinger presented other criteria that add extraspinal involvement that allowed…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology